Your browser doesn't support javascript.
loading
Extension of a pilot study: impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness.
Chou, W H; Yan, F X; de Leon, J; Barnhill, J; Rogers, T; Cronin, M; Pho, M; Xiao, V; Ryder, T B; Liu, W W; Teiling, C; Wedlund, P J.
Affiliation
  • Chou WH; Division of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington 40536-0082, USA.
J Clin Psychopharmacol ; 20(2): 246-51, 2000 Apr.
Article in En | MEDLINE | ID: mdl-10770465
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / Psychotic Disorders / Antipsychotic Agents / Cytochrome P-450 CYP2D6 Type of study: Health_economic_evaluation / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: J Clin Psychopharmacol Year: 2000 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / Psychotic Disorders / Antipsychotic Agents / Cytochrome P-450 CYP2D6 Type of study: Health_economic_evaluation / Risk_factors_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: J Clin Psychopharmacol Year: 2000 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos